Contribution of ionic silver to genotoxic potential of nanosilver in human liver HepG2 and colon Caco2 cells evaluated by the cytokinesis-block micronucleus assay

• Published in: Journal of applied toxicology Vol. 36; no. 4; pp. 532 - 542
• Main Authors: Sahu, Saura C., Roy, Shambhu, Zheng, Jiwen, Ihrie, John
• Format: Journal Article
• Language: English
• Published: England Blackwell Publishing Ltd 01.04.2016; Wiley Subscription Services, Inc
• Subjects: Acetates; Assaying; Caco-2 Cells; Caco2; Colon - cytology; Colon - drug effects; Colon - metabolism; Concentration (composition); Cytokines; Cytokinesis - drug effects; cytokinesis-block micronucleus; DNA Damage - drug effects; Endpoint Determination; Genotoxicity; Hep G2 Cells; HepG2; Human; Humans; in vitro micronucleus; In vitro testing; Linear Models; Liver; Liver - cytology; Liver - drug effects; Liver - metabolism; Metal Nanoparticles - chemistry; Metal Nanoparticles - toxicity; micronucleus; Micronucleus Tests - methods; Mutagens - toxicity; nanoparticles; nanosilver; Nanostructure; Silver; Silver - chemistry; Silver - toxicity; silver nanoparticles; Toxicity; genotoxicity; micronucleus; nanoparticles; cytokinesis-block micronucleus; silver nanoparticles; Caco2; HepG2; nanosilver; in vitro micronucleus
• ISSN: 0260-437X; 1099-1263
• DOI: 10.1002/jat.3279

Extensive human exposure to food‐ and cosmetics‐related consumer products containing nanosilver is of public concern because of the lack of information about their safety. Genotoxicity is an important endpoint for the safety and health hazard assessment of regulated products including nanomaterials. The in vitro cytokinesis‐block micronucleus (CBMN) assay is a very useful test for predictive genotoxicity testing. Recently, we have reported the genotoxicity of 20 nm nanosilver in human liver HepG2 and colon Caco2 cells evaluated using the CBMN assay. The objective of our present study was three‐fold: (i) to evaluate if HepG2 and Caco2 cells are valuable in vitro models for rapid genotoxicity screening of nanosilver; (ii) to test the hypothesis that the nanoparticle size and cell types are critical determinants of its genotoxicity; and (iii) to determine if ionic silver contributes to the nanosilver genotoxicity. With these objectives in mind, we evaluated the genotoxic potential of 50 nm nanosilver of the same shape, composition, surface charge, obtained from the same commercial source, under the same experimental conditions and the same genotoxic CBMN endpoint used for the previously tested 20 nm silver. The ionic silver (silver acetate) was also evaluated under the same conditions. Results of our study show that up to the concentrations tested in these cell types, the smaller (20 nm) nanosilver induces micronucleus formation in both the cell types but the larger (50 nm) nanosilver and the ionic silver provide a much weaker response compared with controls under the same conditions. Published 2016. This article is a U.S. Government work and is in the public domain in the USA. Recently, we have reported the genotoxicity of 20 nm nanosilver evaluated using the in vitro cytokinesis‐block micronucleus (CBMN) assay. In this study, we evaluated the genotoxic potential of 50 nm nanosilver of the same shape, composition, surface charge, obtained from the same commercial source, under the same experimental conditions and the same genotoxic CBMN endpoint used for the previously tested 20 nm silver. The ionic silver (silver acetate) was also evaluated under the same conditions. Results of our study show that up to the concentrations tested in these cell types, the smaller (20 nm) nanosilver induces micronucleus formation in both the cell types but the larger (50 nm) nanosilver and the ionic silver provide much weaker response compared with controls under the same conditions.